Interchange Capital Partners LLC Buys Shares of 6,567 Tempus AI, Inc. (NASDAQ:TEM)

Interchange Capital Partners LLC purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) in the 4th quarter, Holdings Channel.com reports. The firm purchased 6,567 shares of the company’s stock, valued at approximately $214,000.

Other hedge funds have also recently modified their holdings of the company. First Horizon Advisors Inc. purchased a new position in Tempus AI during the 3rd quarter worth $30,000. Farther Finance Advisors LLC acquired a new stake in Tempus AI in the fourth quarter valued at about $34,000. FNY Investment Advisers LLC purchased a new stake in Tempus AI in the 4th quarter valued at approximately $67,000. IFP Advisors Inc acquired a new position in Tempus AI during the 4th quarter worth approximately $76,000. Finally, US Bancorp DE purchased a new position in shares of Tempus AI during the 4th quarter worth approximately $80,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Stock Performance

Shares of NASDAQ:TEM opened at $59.00 on Tuesday. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The business’s fifty day moving average price is $56.88 and its two-hundred day moving average price is $51.40. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $91.45.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on TEM shares. Wolfe Research lowered Tempus AI from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 26th. William Blair reiterated a “market perform” rating on shares of Tempus AI in a report on Tuesday, February 25th. Guggenheim reiterated a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Piper Sandler lowered their target price on shares of Tempus AI from $70.00 to $55.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 4th. Finally, Bank of America lifted their price target on shares of Tempus AI from $54.00 to $60.00 and gave the company a “neutral” rating in a research report on Monday, March 3rd. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, Tempus AI has an average rating of “Moderate Buy” and a consensus price target of $61.18.

Insider Activity

In other Tempus AI news, EVP Andrew Polovin sold 13,135 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $45.98, for a total transaction of $603,947.30. Following the transaction, the executive vice president now owns 154,171 shares of the company’s stock, valued at $7,088,782.58. This represents a 7.85 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Nadja West sold 809 shares of Tempus AI stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $51.11, for a total value of $41,347.99. Following the completion of the sale, the director now directly owns 37,705 shares of the company’s stock, valued at approximately $1,927,102.55. This represents a 2.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,598,969 shares of company stock worth $317,194,162 over the last three months.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.